NFKB1 and glioma: Many of these molecules seem to converge on the same inflammatory pathways that are aberrant in glioma, which include the activation of NF-κB, COX-2, and NLRP3, providing a mechanistic basis for potential chemopreventive and adjunct therapeutic roles [12,19,21].